Syndrome News and Research

RSS
MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Study models the airborne transmission of COVID-19 in a hospital outpatient examination room

Study models the airborne transmission of COVID-19 in a hospital outpatient examination room

Association between polyunsaturated fatty acid levels and COVID-19 prognosis

Association between polyunsaturated fatty acid levels and COVID-19 prognosis

Prevalence of breastmilk feeding among people with SARS-CoV-2 infection during pregnancy

Prevalence of breastmilk feeding among people with SARS-CoV-2 infection during pregnancy

Study sheds light on biomechanistic reasons why allergic asthma correlates with milder forms of COVID-19

Study sheds light on biomechanistic reasons why allergic asthma correlates with milder forms of COVID-19

Study sheds light on the conformational dynamics of SARS-CoV-1 and SARS-CoV-2 spike proteins

Study sheds light on the conformational dynamics of SARS-CoV-1 and SARS-CoV-2 spike proteins

Role of SARS-CoV-2 S1 subunit in severe COVID-19

Role of SARS-CoV-2 S1 subunit in severe COVID-19

Inconsistency in disease severity across SARS-CoV-2 variants

Inconsistency in disease severity across SARS-CoV-2 variants

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

SARS-CoV-2 and pandemic chilblains

SARS-CoV-2 and pandemic chilblains

COMBINEDBrain Biorepository: A comprehensive approach to speed research for rare diseases

COMBINEDBrain Biorepository: A comprehensive approach to speed research for rare diseases

NYU Langone joins NIH-sponsored program as leading center to discover new targets for autoimmune, inflammatory diseases

NYU Langone joins NIH-sponsored program as leading center to discover new targets for autoimmune, inflammatory diseases

A summary of SARS-CoV-2 RNA-protein interactome studies

A summary of SARS-CoV-2 RNA-protein interactome studies

Study identifies 10 new genetic regions linked with Brugada syndrome

Study identifies 10 new genetic regions linked with Brugada syndrome

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

Minimal system for SARS-CoV-2 based virus-like particle production to study viral assembly and entry

Minimal system for SARS-CoV-2 based virus-like particle production to study viral assembly and entry

Researchers create method to track SARS-CoV-2 RBD binding in vivo

Researchers create method to track SARS-CoV-2 RBD binding in vivo

Study examines pediatric emergency department attendance trends during the first COVID-19 wave in Europe

Study examines pediatric emergency department attendance trends during the first COVID-19 wave in Europe

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.